Description
DIGOXIN FOR CONSOLIDATED MAIL ORDER PHARMACIES (CMOP) NATIONWIDE MODIFICATION P00002
Base award description: DIGOXIN FOR CONSOLIDATED MAIL ORDER PHARMACIES (CMOP) NATIONWIDE
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-02-05+$381,682= $381,682
- Mod P000012016-02-19-$26,259= $355,423
- Mod P000022016-03-01+$0= $355,423
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-02-05 | +$381,682 | $381,682 | DIGOXIN FOR CONSOLIDATED MAIL ORDER PHARMACIES (CMOP) NATIONWIDE |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2016-02-19 | −$26,259 | $355,423 | DIGOXIN FOR CONSOLIDATED MAIL ORDER PHARMACIES (CMOP) NATIONWIDE MODIFICATION P00001 |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2016-03-01 | +$0 | $355,423 | DIGOXIN FOR CONSOLIDATED MAIL ORDER PHARMACIES (CMOP) NATIONWIDE MODIFICATION P00002 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PUM1KHA7QA79)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77025P0226 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $289,027 | FY2025 |
| 36F79725D0072 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2025 |
| 36F79724D0032 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36F79724D0004 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2024 |
| 36C77022P0383 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $21,067 | FY2022 |
| 36C77022P0319 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $66,420 | FY2022 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA77016P0844 | ROCHE DIABETES CARE INC | NATIONAL CMOP OFFICE (NCO) | $494,384 | FY2016 |
| VA77016P0843 | D & H WHOLESALE MEDICAL, INC. | NATIONAL CMOP OFFICE (NCO) | $30,360 | FY2016 |
| VA77016E0865 | SOUND PACKAGING LLC | NATIONAL CMOP OFFICE (NCO) | $11,462 | FY2016 |
| VA77016P0828 | WESTMINSTER PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (NCO) | $24,615 | FY2016 |
| VA77016E0862 | 3M COMPANY | NATIONAL CMOP OFFICE (NCO) | $9,177 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA77016P0551_3600_-NONE-_-NONE- · retrieved 2026-09-26.